Last update 01 Nov 2024
Chengdu Hepatunn Pharmaceutical Co. Ltd.
Last update 01 Nov 2024
Overview
Tags
Skin and Musculoskeletal Diseases
Nervous System Diseases
Endocrinology and Metabolic Disease
Small molecule drug
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
评估格隆溴铵新斯的明注射液拮抗肌松残留阻滞作用的有效性和安全性多中心、随机、双盲、硫酸阿托品联合甲硫酸新斯的明、平行对照III期临床试验
[Translation] To evaluate the efficacy and safety of glycopyrrolate-neostigmine injection in antagonizing the residual blocking effect of muscle relaxants: a multicenter, randomized, double-blind, parallel-controlled phase III clinical trial of atropine sulfate combined with neostigmine methylsulfate
评价中国全麻术后患者单次静注格隆溴铵新斯的明注射液拮抗肌松残留阻滞的安全性和药代动力学特征的研究
[Translation] A study to evaluate the safety and pharmacokinetic characteristics of a single intravenous injection of glycopyrrolate and neostigmine injection to antagonize residual blockade of muscle relaxation in Chinese patients after general anesthesia
100 Clinical Results associated with Chengdu Hepatunn Pharmaceutical Co. Ltd.
Login to view more data
Login to view more data
100 Deals associated with Chengdu Hepatunn Pharmaceutical Co. Ltd.
Login to view more data
100 Translational Medicine associated with Chengdu Hepatunn Pharmaceutical Co. Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 04 Nov 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1 Clinical
1
2
Approved
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free